v3.26.1
SEGMENT INFORMATION - Schedule of Total Revenues and Disaggregates Net Product Revenues by Product (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue from External Customer [Line Items]    
Total revenues $ 766,208 $ 745,145
Net product revenues    
Revenue from External Customer [Line Items]    
Total revenues 760,078 734,644
VOXZOGO    
Revenue from External Customer [Line Items]    
Total revenues 219,880 213,754
VIMIZIM    
Revenue from External Customer [Line Items]    
Total revenues 210,204 188,346
NAGLAZYME    
Revenue from External Customer [Line Items]    
Total revenues 130,074 114,290
PALYNZIQ    
Revenue from External Customer [Line Items]    
Total revenues 89,558 93,269
BRINEURA    
Revenue from External Customer [Line Items]    
Total revenues 47,104 40,362
ALDURAZYME    
Revenue from External Customer [Line Items]    
Total revenues 36,742 48,977
KUVAN    
Revenue from External Customer [Line Items]    
Total revenues 23,880 25,136
ROCTAVIAN    
Revenue from External Customer [Line Items]    
Total revenues 2,636 10,510
Royalty and other revenues    
Revenue from External Customer [Line Items]    
Total revenues $ 6,130 $ 10,501